Home/Ventyx Biosciences/Christopher Krueger, Ph.D.
CK

Christopher Krueger, Ph.D.

Former Chief Scientific Officer

Ventyx Biosciences

Ventyx Biosciences Pipeline

DrugIndicationPhase
VTX002Ulcerative ColitisPhase 2
VTX2735Systemic Inflammatory DiseasesPhase 1
VTX3232CNS / Neuroinflammatory DiseasesPreclinical/Phase 1